Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety
<p>Abstract</p> <p>Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-05-01
|
Series: | Patient Safety in Surgery |
Online Access: | http://www.pssjournal.com/content/2/1/13 |